These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 6713036)

  • 1. Phenylacetic acid excretion in schizophrenia and depression: the origins of PAA in man.
    Karoum F; Potkin S; Chuang LW; Murphy DL; Liebowitz MR; Wyatt RJ
    Biol Psychiatry; 1984 Feb; 19(2):165-78. PubMed ID: 6713036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical studies on the phenylethylamine hypothesis of affective disorder: urine and blood phenylacetic acid and phenylalanine dietary supplements.
    Sabelli HC; Fawcett J; Gusovsky F; Javaid JI; Wynn P; Edwards J; Jeffriess H; Kravitz H
    J Clin Psychiatry; 1986 Feb; 47(2):66-70. PubMed ID: 3944066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenylethylamine (PEA) and phenylacetic acid (PAA) in the urine of chronic schizophrenic patients and controls.
    Potkin SG; Wyatt RJ; Karoum F
    Psychopharmacol Bull; 1980 Jan; 16(1):52-4. PubMed ID: 7360842
    [No Abstract]   [Full Text] [Related]  

  • 4. Urinary trace amine excretion and platelet monoamine oxidase activity in schizophrenia.
    Yoshimoto S; Kaku H; Shimogawa S; Watanabe A; Nakagawara M; Takahashi R
    Psychiatry Res; 1987 Jul; 21(3):229-36. PubMed ID: 3628609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary phenyl acetate: a diagnostic test for depression?
    Sabelli HC; Fawcett J; Gusovsky F; Javaid J; Edwards J; Jeffriess H
    Science; 1983 Jun; 220(4602):1187-8. PubMed ID: 6857245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenylethylamine excretion in depression.
    DeLisi LE; Murphy DL; Karoum F; Mueller E; Targum S; Wyatt RJ
    Psychiatry Res; 1984 Nov; 13(3):193-201. PubMed ID: 6597458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary phenylacetic acid excretion in depressive patients.
    González-Sastre F; Mora J; Guillamat R; Queraltó JM; Alvarez E; Udina C; Massana J
    Acta Psychiatr Scand; 1988 Aug; 78(2):208-10. PubMed ID: 3223321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis and the effects of some drugs on the metabolism of phenylethylamine and phenylacetic acid.
    McQuade PS
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(4-6):607-14. PubMed ID: 6152342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary phenylacetate and response to methylphenidate.
    Baxter LR; Kelly RC; Peter JB; Liston EH; Touserkani S
    J Psychiatr Res; 1988; 22(2):131-9. PubMed ID: 3404481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Excretion of 3,4-dimethoxy phenylethylamine in the urine of schizophrenics].
    Zimmermann K; Moschke P; Wieder KH
    Psychiatr Neurol Med Psychol (Leipz); 1976 Mar; 28(3):163-73. PubMed ID: 967948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism distribution, and disappearance of injected beta-phenylethylamine in the rat.
    Wu PH; Boulton AA
    Can J Biochem; 1975 Jan; 53(1):42-50. PubMed ID: 1120290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary tryptamine excretion in chronic schizophrenics with low platelet MAO activity.
    Sullivan JL; Coffey CE; Basuk B; Cavenar JO; Maltbie AA; Zung WW
    Biol Psychiatry; 1980 Feb; 15(1):113-20. PubMed ID: 7357050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of dietary phenylalanine on the plasma concentrations of phenylalanine, phenylethylamine and phenylacetic acid in healthy volunteers.
    Davis BA; O'Reilly RL; Placatka CL; Paterson IA; Yu PH; Durden DA
    Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(5):611-23. PubMed ID: 1956990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenylacetic acid in CSF and serum in Indian schizophrenic patients.
    Davis BA; Shrikhande S; Paralikar VP; Hirsch SR; Durden DA; Boulton AA
    Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(1):41-7. PubMed ID: 2008539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoamine oxidase inhibitors potentiate phenylethylamine effects in rhesus monkeys.
    Staub RA; Gillin JC; Wyatt RJ
    Biol Psychiatry; 1980 Jun; 15(3):429-36. PubMed ID: 6769508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High phenylacetic acid differentiates schizoaffective from schizophrenic patients.
    Sabelli HC; Durai UN; Fawcett J; Javaid JI
    J Neuropsychiatry Clin Neurosci; 1989; 1(1):37-9. PubMed ID: 2535427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenylethylamine and phenylacetic acid in CSF of schizophrenics and healthy controls.
    Beckmann H; Reynolds GP; Sandler M; Waldmeier P; Lauber J; Riederer P; Gattaz WF
    Arch Psychiatr Nervenkr (1970); 1983; 232(6):463-71. PubMed ID: 6134517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenylethylamine metabolism in Tourette's syndrome.
    Bornstein RA; Baker GB; Carroll A; King G; Ashton S
    J Neuropsychiatry Clin Neurosci; 1990; 2(4):408-12. PubMed ID: 2136393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenylethylaminergic mechanisms in attention-deficit disorder.
    Baker GB; Bornstein RA; Rouget AC; Ashton SE; van Muyden JC; Coutts RT
    Biol Psychiatry; 1991 Jan; 29(1):15-22. PubMed ID: 2001444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary phenylacetic acid in panic disorder with and without depression.
    Sabelli HC; Javaid JI; Fawcett J; Kravitz HM; Wynn P
    Acta Psychiatr Scand; 1990 Jul; 82(1):14-6. PubMed ID: 2399814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.